# FDA 483 - Kelada Creative Group, LLC - February 01, 2019

Source: https://www.globalkeysolutions.net/records/483/kelada-creative-group-llc/4a710939-b048-4842-9c7d-8b3af9547045

> FDA 483 for Kelada Creative Group, LLC on February 01, 2019. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Kelada Creative Group, LLC
- Inspection Date: 2019-02-01
- Product Type: drugs
- Office Name: Dallas District Office
- Summary: An FDA inspection of Kelada Creative Group, LLC, a manufacturer of OTC and homeopathic drugs in Richmond, TX, revealed significant deficiencies in quality control. The firm failed to test raw materials, finished products, or conduct stability studies to determine expiration dates. Additionally, labeling errors were identified, indicating a systemic lack of quality assurance.

## Related Officers

- [Investigator](https://www.globalkeysolutions.net/people/shatina-r-alridge/f4715fcf-fb27-4ef3-8289-adfff2db62bf)

Company: https://www.globalkeysolutions.net/companies/kelada-creative-group-llc/1cc46e8d-a7b5-4ab1-8319-2892aaa24e19

Office: https://www.globalkeysolutions.net/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9